Myriad Genetics Inc
MYGN- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000899923
No open-market purchases or sales by Myriad Genetics Inc insiders were filed in the last 90 days; 196 institutions reported holding it in 13F filings for Q2 2026, worth $507.8M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Myriad Genetics Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Myriad Genetics Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Wheeler Benjamin Richard | Chief Financial Officer | 287,193 | Sep 22, 2026 | 6 |
| Donnelly Brian J | Chief Commercial Officer | 573,363 | Sep 18, 2026 | 4 |
| Sikri Vishal | EVP, Commercial | 351,224 | Sep 17, 2026 | 1 |
| Fox Jennifer Lynne | Chief Legal Officer | 305,964 | Sep 8, 2026 | 2 |
| Skovronsky Daniel | Director | 195,507 | Jun 23, 2026 | 2 |
| Raha Samraat S. | President and CEO | 1,068,083 | Jun 12, 2026 | 4 |
| Kumar Rashmi | Director | 171,889 | Jun 9, 2026 | 2 |
| Bisaro Paul | Director | 157,142 | Jun 5, 2026 | 2 |
| Dreismann Heinrich | Director | 231,145 | Jun 5, 2026 | 1 |
| Phanstiel S. Louise | Director | 341,652 | Jun 5, 2026 | 2 |
| Reitan Colleen F | Director | 152,030 | Jun 5, 2026 | 1 |
| Newcomer Lee Nisley | Director | 191,842 | Jun 5, 2026 | 1 |
| Davis Mark Steven | Director | 106,665 | Jun 5, 2026 | 1 |
| Jampa Raj | Chief Technology Officer | 251,889 | Jun 2, 2026 | 1 |
| Verratti Mark | Chief Operating Officer | 629,646 | Apr 15, 2026 | 4 |
| Muzzey Dale | Chief Scientific Officer | 326,310 | Apr 15, 2026 | 5 |
| Solaiman Shereen | Chief People Officer | 267,801 | Mar 16, 2026 | 2 |
| Haas Kevin Richard | Chief Technology Officer | 180,022 | Mar 16, 2026 | 2 |
| Ancona Margaret | EVP, Strategy & Transformation | 127,726 | Nov 4, 2025 | 1 |
| Munk Natalie | Chief Accounting Officer | 45,167 | Oct 24, 2025 | 1 |
| Leffler Scott J. | Chief Financial Officer | 218,393 | Aug 18, 2025 | 0 |
| Diaz Paul J | President and CEO | 891,844 | Apr 30, 2025 | 0 |
| Spiegelman Daniel K | Director | 32,917 | Jun 7, 2024 | 0 |
| Wong Pamela | Chief Legal Officer | 65,002 | Mar 25, 2024 | 0 |
| Riggsbee Richard Bryan | Chief Financial Officer | 291,812 | Jan 31, 2024 | 0 |
| Lambert Nicole | Chief Operating Officer | 223,993 | Nov 1, 2023 | 0 |
| Hart Jayne B. | See Remarks | 172,561 | Mar 2, 2023 | 0 |
| Langer Dennis | Director | 106,802 | Jun 30, 2022 | 0 |
| Santa Eric | Former Chief Growth Officer | 56,734 | Apr 26, 2022 | 0 |
| Lanchbury Jerry S | See Remarks | 264,324 | Jan 18, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 9, 2026 (view filing) | Jun 8 | 1 day | Kumar RashmiDirector | SSale | −15.0K | $4.46 | −$66.9K | −8.0%171.9K after | 10b5-1 |
| May 14, 2026 (view filing) | May 14 | Same day | Bisaro PaulDirector | PPurchase | +7.50K | $3.69 | +$27.7K | +8.3%97.4K after | |
| Mar 9, 2026 (view filing) | Mar 9 | Same day | Raha Samraat S.President and CEO | PPurchase | +40.0K | $5.00 | +$200.0K | +8.8%493.1K after | |
| Feb 27, 2026 (view filing) | Feb 25-27 | 2 days | Phanstiel S. LouiseDirector | PPurchase | +104.5K | $4.73 | +$494.5K | +58.9%282.0K after | 3 lots |
| Oct 11, 2024 (view filing) | Oct 11 | Same day | Diaz Paul JPresident and CEO | SSale | −15.0K | $22.93 | −$343.9K | −1.5%962.4K after | 10b5-1 |
| Sep 12, 2024 (view filing) | Sep 11 | 1 day | Muzzey DaleChief Scientific Officer | SSale | −2.10K | $26.17 | −$55.0K | −1.9%108.0K after | |
| Sep 12, 2024 (view filing) | Sep 11 | 1 day | Diaz Paul JPresident and CEO | SSale | −15.0K | $26.72 | −$400.8K | −1.5%977.4K after | 10b5-1 |
| Sep 9, 2024 (view filing) | Sep 9 | Same day | Dreismann HeinrichDirector | SSale | −10.0K | $27.05 | −$270.5K | −7.6%121.6K after | |
| Sep 4, 2024 (view filing) | Sep 3 | 1 day | Reitan Colleen FDirector | SSale | −46.0K | $27.95 | −$1.29M | −52.0%42.5K after | 10b5-1 |
| Aug 23, 2024 (view filing) | Aug 21 | 2 days | Ancona MargaretSVP, Chief of Staff | SSale | −11.5K | $27.82 | −$321.0K | −12.7%79.4K after | |
| Aug 20, 2024 (view filing) | Aug 19 | 1 day | Kumar RashmiDirector | SSale | −7.50K | $28.01 | −$210.1K | −8.8%77.4K after | 10b5-1 |
| Jun 4, 2024 (view filing) | Jun 3-4 | 1 day | Spiegelman Daniel KDirector | SSale | −7.58K | $22.05 | −$167.0K | −18.7%32.9K after | 2 lots10b5-1 |
| May 15, 2024 (view filing) | May 13 | 2 days | Newcomer Lee NisleyDirector | SSale | −6.20K | $25.30 | −$156.9K | −8.5%66.7K after | |
| May 15, 2024 (view filing) | May 13-15 | 2 days | Diaz Paul JPresident and CEO | SSale | −227.8K | $25.14 | −$5.73M | −17.6%1.07M after | 3 lots |
| Dec 5, 2023 (view filing) | Dec 1 | 4 days | Riggsbee Richard BryanChief Financial Officer | SSale | −30.0K | $19.09 | −$572.7K | −9.3%291.8K after | 10b5-1 |
| Nov 3, 2023 (view filing) | Nov 1 | 2 days | Riggsbee Richard BryanChief Financial Officer | SSale | −30.0K | $15.69 | −$470.7K | −8.5%321.8K after | 10b5-1 |
| Jun 2, 2023 (view filing) | Jun 2 | Same day | Spiegelman Daniel KDirector | SSale | −8.64K | $23.01 | −$198.8K | −17.6%40.5K after | |
| Mar 28, 2023 (view filing) | Mar 27 | 1 day | Lambert NicoleChief Operating Officer | SSale | −6.43K | $23.48 | −$151.0K | −2.6%240.5K after | |
| Mar 3, 2023 (view filing) | Mar 2 | 1 day | Lambert NicoleChief Operating Officer | SSale | −13.2K | $22.74 | −$299.8K | −5.8%215.2K after | |
| Mar 3, 2023 (view filing) | Mar 2 | 1 day | Riggsbee Richard BryanChief Financial Officer | SSale | −15.0K | $22.55 | −$338.3K | −4.3%337.9K after | |
| Jan 23, 2023 (view filing) | Jan 20 | 3 days | Riggsbee Richard BryanChief Financial Officer | SSale | −9.40K | $20.04 | −$188.4K | −2.5%364.1K after | |
| Jan 19, 2023 (view filing) | Jan 18 | 1 day | Riggsbee Richard BryanChief Financial Officer | SSale | −600 | $20.01 | −$12.0K | −0.2%373.5K after | |
| Dec 28, 2022 (view filing) | Dec 27 | 1 day | Riggsbee Richard BryanChief Financial Officer | SSale | −20.0K | $15.15 | −$303.0K | −5.1%374.1K after | |
| Jun 6, 2022 (view filing) | Jun 6 | Same day | Spiegelman Daniel KDirector | SSale | −6.42K | $19.25 | −$123.7K | −15.9%34.0K after | |
| Mar 1, 2022 (view filing) | Feb 28 | 1 day | Hart Jayne B.Chief People Officer | SSale | −10.5K | $25.00 | −$262.5K | −6.0%165.9K after | 2 lots |
| Oct 4, 2021 (view filing) | Oct 1 | 3 days | Lambert NicoleSee Remarks | SSale | −1.42K | $31.57 | −$44.8K | −0.8%176.7K after | |
| Sep 27, 2021 (view filing) | Sep 27 | Same day | Lambert NicoleSee Remarks | SSale | −10.1K | $33.10 | −$334.7K | −5.4%178.1K after | |
| Sep 27, 2021 (view filing) | Sep 23 | 4 days | Lanchbury Jerry SChief Scientific Officer | SSale | −200 | $35.06 | −$7.01K | −0.1%288.5K after | |
| Sep 21, 2021 (view filing) | Sep 17 | 4 days | Hart Jayne B.Chief People Officer | SSale | −67.4K | $33.72 | −$2.27M | −42.9%89.6K after | 2 lots |
| Aug 30, 2021 (view filing) | Aug 27 | 3 days | Lambert NicoleSee Remarks | SSale | −945 | $34.50 | −$32.6K | −0.7%127.1K after | |
| Aug 25, 2021 (view filing) | Aug 23-24 | 2 days | Lanchbury Jerry SChief Scientific Officer | SSale | −80.0K | $35.32 | −$2.83M | −25.6%232.6K after | 3 lots |
| Aug 6, 2021 (view filing) | Aug 5 | 1 day | Phanstiel S. LouiseDirector | SSale | −47.9K | $35.04 | −$1.68M | −43.7%61.6K after | |
| Aug 6, 2021 (view filing) | Aug 5 | 1 day | Lanchbury Jerry SChief Scientific Officer | SSale | −28.2K | $35.57 | −$1.00M | −10.8%232.6K after | |
| Aug 5, 2021 (view filing) | Aug 3 | 2 days | Riggsbee Richard BryanChief Financial Officer | SSale | −15.0K | $35.14 | −$526.5K | −4.4%324.9K after | |
| Aug 5, 2021 (view filing) | Aug 3 | 2 days | Langer DennisDirector | SSale | −30.0K | $34.75 | −$1.04M | −25.1%89.5K after | |
| Aug 5, 2021 (view filing) | Aug 3-4 | 2 days | Lanchbury Jerry SChief Scientific Officer | SSale | −100.0K | $34.68 | −$3.47M | −30.1%232.6K after | 6 lots |
| Jul 14, 2021 (view filing) | Jul 12-13 | 2 days | Lanchbury Jerry SChief Scientific Officer | SSale | −93.3K | $33.64 | −$3.14M | −28.6%232.6K after | 4 lots |
| Jul 12, 2021 (view filing) | Jul 9 | 3 days | Lanchbury Jerry SChief Scientific Officer | SSale | −50.0K | $32.62 | −$1.63M | −17.7%232.6K after | 3 lots |
| Jul 8, 2021 (view filing) | Jul 7 | 1 day | Lanchbury Jerry SChief Scientific Officer | SSale | −32.3K | $32.27 | −$1.04M | −12.2%232.6K after | 2 lots |